The Guardian - Back to home

    Single Covid vaccine dose in Israel 'less effective than we thought'

    Surge in infections dampens optimism over country’s advanced immunisation programme

    An Israeli medical worker prepares a dose of Covid-19 vaccine in Tel Aviv on 17 January.
    An Israeli medical worker prepares a dose of Covid-19 vaccine in Tel Aviv on 17 January. Photograph: Xinhua/Rex

    Last modified on Tue 19 Jan 2021 23.37 EST

    Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNTech vaccine may be providing less protection than originally hoped, as the country reported a record 10,000 new Covid infections on Monday.

    In remarks reported by Army Radio, Nachman Ash said a single dose appeared “less effective than we had thought”, and also lower than Pfizer had suggested.

    By contrast, those who had received their second dose of the Pfizer vaccine had a six- to 12-fold increase in antibodies, according to data released by Sheba Medical Center in Tel Hashomer on Monday.

    The issue of some vaccines being less effective after a single dose rather than two is well known, as well as the fact that protection is not immediate. While the first dose can take several weeks to promote an effective antibody response, the second dose can trigger different responses, supercharging the protection. Pfizer itself says a single dose of its vaccine is about 52% effective. Some countries such as the UK have delayed administering their second doses to try to maximise the number of people given a first dose.

    Questions over the effectiveness of the vaccine were raised amid reports that thousands of Israelis were still becoming sick after receiving the vaccine, although the public health services head, Sharon Alroy-Preis, said that in most cases this was because the individuals had not built up sufficient antibodies after being inoculated before being exposed to the virus.

    The latest figures for Israel, which has implemented one of the fastest national vaccine efforts, underscore the huge challenges still being faced around the globe even in countries with aggressive coronavirus vaccine programmes.

    Already more than 2 million Israelis have had their first Pfizer shot, while 400,000 have had a second.

    Amid warnings that 30% to 40% of the new infections were being driven by a Covid-19 variant first identified in the UK, the Israeli cabinet was meeting on Tuesday to consider tightening existing restrictions. Some analysts, however, have put the prevalence of the new variant at lower levels.

    The cabinet had been warned by Ash that the new variant was set to become the main source of infections in Israel within weeks.

    The new concern follows the release of data on Monday by Israel’s health ministry recording 10,021 infections the previous day, with a positivity rate above the 10% mark for the first time in more than three months, suggesting widespread community transmission.

    The rates of infection have undercut the sense of optimism that the Israeli prime minister, Benjamin Netanyahu, has tried to project around Israel’s vaccination campaign, for which he has taken credit.

    Opening the cabinet meeting on Tuesday, Netanyahu said: “We are in a tight race between the vaccination campaign and the high infection rates in the world due to the mutation.” He called for a “last ditch effort” against the virus.

    Israel is in the midst of a third lockdown, due to end on Thursday. Other measures under consideration include closing the country’s main aviation hub, Ben Gurion international airport, to all except essential flights.

    The rise in new cases has provoked a round of finger pointing, not least at lax policing of the ultra-Orthodox community, where some schools have remained open and there have been large gatherings, including a wedding in Bnei Brak on Monday, described as “scandalous”, which drew 300 guests before being raided by police.

    Describing the impact of the new coronavirus variant, Alroy-Preis told Kan radio that the new variant appeared to be having a significant impact on infections in the ultra-Orthodox community.

    “We’re seeing very significant and rapid infections and it’s really a race between this and the vaccine,” said Alroy-Preis, adding that one person who recently returned from the UK had infected 20 to 30 people.

    Since you're here ...

    ... we have a favour to ask. Millions are flocking to the Guardian for open, independent, quality news every day. Readers in all 50 states and in 180 countries around the world now support us financially.

    With the inauguration of Joe Biden and Kamala Harris, American democracy has a chance to reset. The new administration has a historic opportunity to address the country’s deepest systemic challenges, and steer it toward a path of fairness, equality and stability.

    It won’t be easy. Donald Trump’s chaotic presidency has ended, but the forces that propelled him – from a misinformation crisis to a surge in white nationalism to a crackdown on voting rights – remain clear threats to American democracy. The need for fact-based reporting that highlights injustice and offers solutions is as great as ever. In the coming year, the Guardian will also continue to confront America’s many systemic challenges – from the climate emergency to broken healthcare to rapacious corporations.

    We believe everyone deserves access to information that’s grounded in science and truth, and analysis rooted in authority and integrity. That’s why we made a different choice: to keep our reporting open for all readers, regardless of where they live or what they can afford to pay. In these perilous times, an independent, global news organisation like the Guardian is essential. We have no shareholders or billionaire owner, meaning our journalism is free from commercial and political influence.

    If there were ever a time to join us, it is now. Your funding powers our journalism. Make a gift now from as little as $1. Thank you.

    Accepted payment methods: Visa, Mastercard, American Express and PayPal